Welcome to our dedicated page for Revitalist Lifes news (Ticker: RVLWF), a resource for investors and traders seeking the latest updates and insights on Revitalist Lifes stock.
Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTCQB: RVLWF, FSE: 4DO) generates news that reflects its role in the ketamine and psychedelic wellness segment of mental health care. Company announcements highlight its focus on comprehensive care in the ketamine wellness space, combining clinic operations, telemedicine, partnerships, and advocacy initiatives.
News coverage for Revitalist includes updates on its mental health and wellness services, such as expansions of physical clinic locations and virtual offices across the United States, and joint-venture agreements that broaden access to ketamine therapies and related services. Releases have described brick-and-mortar services in multiple U.S. cities, virtual telemedicine offerings across numerous states, and managed service agreements with other health and wellness facilities.
Investors and observers can also find news on Revitalist’s product collaborations and supplement initiatives. For example, the company has announced the Lion's Brain supplement line, a cobranded joint-venture with Wake Network that combines Revitalist’s proprietary formula with medicinal mushrooms and other ingredients aimed at supporting mental clarity and wellbeing. Additional news items describe evidence-based clinical retreats and neurologically focused supplements developed with partners.
Capital markets and regulatory developments are another key theme in Revitalist’s news flow. The company has issued releases about non-brokered private placements, unit offerings with share purchase warrants, and the use of proceeds for operations and financial reporting. It has also reported on a cease trade order issued by the British Columbia Securities Commission related to delayed financial filings, subsequent filing of audited financial statements, and steps toward addressing regulatory requirements.
Revitalist’s news feed further covers community and professional engagement, including sponsorship of The American Legion’s national convention to support veteran mental health, and speaking engagements on psychedelics in anesthesia at professional congresses. Readers following RVLWF news can track how the company communicates its role in the evolving field of ketamine and psychedelic wellness, its partnerships, financing activities, and regulatory updates over time.
Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTC: RVLWF) is partnering with the US Department of Veterans Affairs to provide mental health services for veterans suffering from treatment-resistant conditions. The initiative comes in response to a crisis with over 65,000 veteran suicides since 2010. The company has a strong focus on veteran health, led by experienced military professionals, aiming to offer comprehensive care in a supportive environment. CEO Kathryn Walker emphasizes their commitment to honoring veterans through quality care.
Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTC: RVLWF) has partnered with Enterprise Stress Management (ESM) to create mental health therapies specifically for police officers in Canada. ESM, led by founder Katherine Plewa, focuses on reducing workplace stress through innovative techniques. Revitalist aims to contribute positively to law enforcement by prioritizing the mental well-being of police officers. Revitalist operates five clinics in the U.S. and provides treatments for various mental health conditions since its establishment in 2018.
Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTC: RVLWF) has announced that CEO Kathryn Walker will speak at the prestigious Wonderland conference on November 8, 2021, in Miami. The event focuses on psychedelic medicine, addressing the urgent need for psychedelic-assisted psychotherapy clinics amid a growing mental health crisis, estimated to cost US$16 trillion. Walker emphasizes the importance of collaboration post-COVID-19 to tackle mental health issues. The event gathers industry leaders, researchers, and investors to foster dialogue and innovation in psychedelic treatments.
Revitalist Lifestyle and Wellness Ltd. has announced its eligibility for Depository Trust Company (DTC) services, enhancing trading access for U.S. investors under the ticker RVLWF. CEO Kathryn Walker expressed enthusiasm about this milestone, which aims to broaden investor access and liquidity in the U.S. market. The DTC facilitates electronic clearing and settlement, easing stock trading processes. Revitalist operates five clinics across the U.S. and is committed to improving wellness through innovative treatment options.
Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTC: RVLWF) has signed a binding letter of intent on October 25, 2021, to acquire a ketamine clinic in Jacksonville, Florida, marking its eighth clinic in five states. The clinic, established in 2017 and managed by Dr. Nicholas Kalynych, specializes in ketamine infusion treatments for mood disorders and chronic pain syndromes. The acquisition, estimated at $100,000, will be partly funded by shares and cash. With this move, Revitalist aims to enhance its brand visibility and healthcare services, especially for the local veteran community.
Revitalist Lifestyle and Wellness Ltd. has announced a new lease for a location in Powell, Tennessee, extending its operational footprint. The lease covers 3,500 square feet initially, with an option for an additional 4,500 square feet, potentially increasing total revenue capacity from approximately $3.55 million to $7.1 million annually. This expansion reflects the company's growth since establishing its first clinic in the area in 2018, driven by high demand for its wellness services.
Revitalist Lifestyle and Wellness Ltd. (CSE: CALM; OTC: RVLWF) announced that Clarus Securities Inc. has published an initial research report on the company. This report and any future publications can be directly accessed through Clarus. Revitalist clarifies that the opinions and forecasts provided by Clarus are solely those of the firm and do not reflect the views of Revitalist or its management. The company operates five clinics across the U.S., specializing in wellness services for treatment-resistant conditions and lifestyle optimization.
Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTC: RVLWF) has announced the launch of intensive outpatient programs (IOP) to enhance patient care. Starting on November 1, 2021, at their Chattanooga clinic, IOP will offer support for patients completing ketamine-assisted psychotherapy (KAP). The program includes three weekly sessions over six weeks at an approximate cost of USD $4,300, eligible for insurance reimbursement. The outpatient mental health industry is projected to grow to USD $34 billion by 2025.
Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTC: RVLWF, FSE: 4DO) has commenced trading on the Frankfurt Stock Exchange (FSE), expanding its presence beyond Canada. This cross-listing aims to enhance liquidity and broaden its investor base in Europe. CEO Kathryn Walker emphasized the importance of this milestone in connecting with international investors. Revitalist has five clinics in the United States, offering comprehensive care, lifestyle optimization services, and over 7,000 treatments for patients with treatment-resistant conditions since 2018.
Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTC: RVLWF) announced its clinics will now collaborate with psychiatric physicians to provide transcranial magnetic stimulation (TMS). This initiative enhances access to insurance-covered TMS care, broadening market share. TMS is a noninvasive treatment for conditions like depression and Alzheimer’s. The global TMS market is projected to grow from
FAQ
What is the current stock price of Revitalist Lifes (RVLWF)?
What is the market cap of Revitalist Lifes (RVLWF)?
